用佐剂福尔马林灭活甲型流感病毒（H5N1）疫苗对猕猴进行接种：预防H5N1攻击且无疾病增强作用。
Vaccination of macaques with adjuvanted formalin-inactivated influenza A virus (H5N1) vaccines: protection against H5N1 challenge without disease enhancement.
作者信息
Ruat Caroline, Caillet Catherine, Bidaut Alexandre, Simon James, Osterhaus Albert D M E
机构信息
Erasmus Medical Center, Rotterdam, The Netherlands.
出版信息
J Virol. 2008 Mar;82(5):2565-9. doi: 10.1128/JVI.01928-07. Epub 2007 Dec 19.
Abstract
We investigated the ability of adjuvanted, inactivated split-virion influenza A virus (H5N1) vaccines to protect against infection and demonstrated that the disease exacerbation phenomenon seen with adjuvanted formaldehyde-inactivated respiratory syncytial virus and measles virus investigational vaccines did not occur with these H5N1 vaccines. Macaques were vaccinated twice with or without an aluminum hydroxide or oil-in-water emulsion adjuvanted vaccine. Three months later, animals were challenged with homologous wild-type H5N1. No signs of vaccine-induced disease exacerbation were seen. With either adjuvant, vaccination induced functional and cross-reactive antibodies and protected the lungs and upper respiratory tract. Without an adjuvant, the vaccine provided partial protection. Best results were obtained with the emulsion adjuvant.
摘要
我们研究了佐剂化的甲型流感病毒（H5N1）裂解灭活病毒疫苗预防感染的能力，并证明佐剂化的甲醛灭活呼吸道合胞病毒和麻疹病毒研究性疫苗所出现的疾病加重现象在这些H5N1疫苗中并未出现。猕猴分别接种了含或不含氢氧化铝或水包油乳剂佐剂的疫苗，共接种两次。三个月后，用同源野生型H5N1对动物进行攻击。未观察到疫苗诱导的疾病加重迹象。无论使用哪种佐剂，接种疫苗均能诱导产生功能性和交叉反应性抗体，并保护肺部和上呼吸道。无佐剂时，疫苗提供部分保护。水包油乳剂佐剂的效果最佳。
相似文献
1
Vaccination of macaques with adjuvanted formalin-inactivated influenza A virus (H5N1) vaccines: protection against H5N1 challenge without disease enhancement.用佐剂福尔马林灭活甲型流感病毒（H5N1）疫苗对猕猴进行接种：预防H5N1攻击且无疾病增强作用。
J Virol. 2008 Mar;82(5):2565-9. doi: 10.1128/JVI.01928-07. Epub 2007 Dec 19.
2
Inactivated and adjuvanted whole-virion clade 2.3.4 H5N1 pre-pandemic influenza vaccine possesses broad protective efficacy against infection by heterologous clades of highly pathogenic H5N1 avian influenza virus in mice.灭活及佐剂全病毒 2.3.4 分支 H5N1 大流行前流感疫苗在小鼠中对异源高致病性 H5N1 禽流感病毒具有广泛的保护效力。
Vaccine. 2011 Oct 26;29(46):8330-7. doi: 10.1016/j.vaccine.2011.08.091. Epub 2011 Sep 10.
3
Cross-protection against lethal H5N1 challenge in ferrets with an adjuvanted pandemic influenza vaccine.用一种佐剂大流行性流感疫苗对雪貂进行致死性H5N1攻击的交叉保护。
PLoS One. 2008 Jan 2;3(1):e1401. doi: 10.1371/journal.pone.0001401.
4
Inactivated influenza H5N1 whole-virus vaccine with aluminum adjuvant induces homologous and heterologous protective immunities against lethal challenge with highly pathogenic H5N1 avian influenza viruses in a mouse model.含铝佐剂的灭活H5N1全病毒疫苗在小鼠模型中可诱导针对高致病性H5N1禽流感病毒致死性攻击的同源和异源保护性免疫。
Vaccine. 2007 May 4;25(18):3554-60. doi: 10.1016/j.vaccine.2007.01.083. Epub 2007 Jan 30.
5
Superior protection provided by a single dose of MF59-adjuvanted whole inactivated H5N1 influenza vaccine in type 1 diabetic mice.MF59 佐剂全灭活 H5N1 流感疫苗在 1 型糖尿病小鼠中提供的优越保护。
Arch Virol. 2011 Mar;156(3):387-95. doi: 10.1007/s00705-010-0860-4. Epub 2010 Nov 26.
6
Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.通过鼻内共同给予杆状病毒表面展示的血凝素（HA）和重组霍乱毒素B亚单位（CTB）作为佐剂，对小鼠进行针对H5N1流感病毒攻击的保护性免疫。
Virology. 2008 Oct 25;380(2):412-20. doi: 10.1016/j.virol.2008.08.002. Epub 2008 Sep 10.
7
Intranasal H5N1 vaccines, adjuvanted with chitosan derivatives, protect ferrets against highly pathogenic influenza intranasal and intratracheal challenge.用壳聚糖衍生物佐剂的鼻内H5N1疫苗可保护雪貂免受高致病性流感病毒的鼻内和气管内攻击。
PLoS One. 2014 May 21;9(5):e93761. doi: 10.1371/journal.pone.0093761. eCollection 2014.
8
Intranasal administration of adjuvant-combined vaccine protects monkeys from challenge with the highly pathogenic influenza A H5N1 virus.鼻腔内给予佐剂联合疫苗可保护猴子免受高致病性 H5N1 流感病毒的挑战。
J Med Virol. 2010 Oct;82(10):1754-61. doi: 10.1002/jmv.21824.
9
Induction of cytotoxic T-lymphocyte and antibody responses against highly pathogenic avian influenza virus infection in mice by inoculation of apathogenic H5N1 influenza virus particles inactivated with formalin.通过接种经福尔马林灭活的无致病性H5N1流感病毒颗粒诱导小鼠针对高致病性禽流感病毒感染产生细胞毒性T淋巴细胞和抗体反应。
Immunology. 2008 Jun;124(2):155-65. doi: 10.1111/j.1365-2567.2007.02745.x. Epub 2008 Jan 16.
10
Matrix-M adjuvanted virosomal H5N1 vaccine confers protection against lethal viral challenge in a murine model.Matrix-M 佐剂的病毒体 H5N1 疫苗可在小鼠模型中提供针对致死性病毒攻击的保护。
Influenza Other Respir Viruses. 2011 Nov;5(6):426-37. doi: 10.1111/j.1750-2659.2011.00256.x. Epub 2011 May 9.
引用本文的文献
1
Pandemic preparedness through vaccine development for avian influenza viruses.通过开发针对禽流感病毒的疫苗做好大流行的准备。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2347019. doi: 10.1080/21645515.2024.2347019. Epub 2024 May 28.
2
Research progress on emulsion vaccine adjuvants.乳化疫苗佐剂的研究进展
Heliyon. 2024 Jan 12;10(3):e24662. doi: 10.1016/j.heliyon.2024.e24662. eCollection 2024 Feb 15.
3
Aerosolized Exposure to H5N1 Influenza Virus Causes Less Severe Disease Than Infection via Combined Intrabronchial, Oral, and Nasal Inoculation in Cynomolgus Macaques.雾化吸入 H5N1 流感病毒引起的疾病比经支气管内、口腔和鼻腔联合接种感染引起的疾病更轻。
Viruses. 2021 Feb 22;13(2):345. doi: 10.3390/v13020345.
4
Comparative Safety and Efficacy Profile of a Novel Oil in Water Vaccine Adjuvant Comprising Vitamins A and E and a Catechin in Protective Anti-Influenza Immunity.一种包含维生素A和E以及一种儿茶素的新型水包油疫苗佐剂在保护性抗流感免疫中的比较安全性和有效性概况。
Nutrients. 2017 May 21;9(5):516. doi: 10.3390/nu9050516.
5
The use of nonhuman primates in research on seasonal, pandemic and avian influenza, 1893-2014.1893年至2014年非人灵长类动物在季节性、大流行性和禽流感研究中的应用
Antiviral Res. 2015 May;117:75-98. doi: 10.1016/j.antiviral.2015.02.011. Epub 2015 Mar 5.
6
H5N1 vaccines in humans.人用 H5N1 疫苗。
Virus Res. 2013 Dec 5;178(1):78-98. doi: 10.1016/j.virusres.2013.05.006. Epub 2013 May 28.
7
H5N1 pathogenesis studies in mammalian models.哺乳动物模型中的 H5N1 发病机制研究。
Virus Res. 2013 Dec 5;178(1):168-85. doi: 10.1016/j.virusres.2013.02.003. Epub 2013 Feb 28.
8
Immunogenic and protective properties of the first Kazakhstan vaccine against pandemic influenza A (H1N1) pdm09 in ferrets.在雪貂中评估哈萨克斯坦首例针对大流行性流感 A（H1N1）pdm09 的疫苗的免疫原性和保护特性。
Virol Sin. 2012 Dec;27(6):345-52. doi: 10.1007/s12250-012-3272-7. Epub 2012 Nov 9.
9
Cross-reactive T cells are involved in rapid clearance of 2009 pandemic H1N1 influenza virus in nonhuman primates.交叉反应性 T 细胞参与了非人类灵长类动物中 2009 年大流行性 H1N1 流感病毒的快速清除。
PLoS Pathog. 2011 Nov;7(11):e1002381. doi: 10.1371/journal.ppat.1002381. Epub 2011 Nov 10.
10
Delta inulin polysaccharide adjuvant enhances the ability of split-virion H5N1 vaccine to protect against lethal challenge in ferrets.Delta 菊糖多聚糖佐剂增强了裂解病毒 H5N1 疫苗对雪貂致命性攻击的保护能力。
Vaccine. 2011 Aug 26;29(37):6242-51. doi: 10.1016/j.vaccine.2011.06.078. Epub 2011 Jul 6.
本文引用的文献
1
H5N1 viruses and vaccines.H5N1病毒与疫苗。
PLoS Pathog. 2007 Mar;3(3):e40. doi: 10.1371/journal.ppat.0030040.
2
Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus.猕猴感染1918年流感病毒致死性感染中的异常先天免疫反应。
Nature. 2007 Jan 18;445(7125):319-23. doi: 10.1038/nature05495.
3
Cross-protectiveness and immunogenicity of influenza A/Duck/Singapore/3/97(H5) vaccines against infection with A/Vietnam/1203/04(H5N1) virus in ferrets.甲型/鸭/新加坡/3/97（H5）流感疫苗对雪貂感染甲型/越南/1203/04（H5N1）病毒的交叉保护作用和免疫原性。
J Infect Dis. 2006 Oct 15;194(8):1040-3. doi: 10.1086/507709. Epub 2006 Sep 12.
4
Live, attenuated influenza A H5N1 candidate vaccines provide broad cross-protection in mice and ferrets.减毒活甲型H5N1流感候选疫苗在小鼠和雪貂中提供广泛的交叉保护。
PLoS Med. 2006 Sep;3(9):e360. doi: 10.1371/journal.pmed.0030360.
5
Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia.人感染甲型H5N1流感的致死结局与高病毒载量和细胞因子血症有关。
Nat Med. 2006 Oct;12(10):1203-7. doi: 10.1038/nm1477. Epub 2006 Sep 10.
6
Immunization with reverse-genetics-produced H5N1 influenza vaccine protects ferrets against homologous and heterologous challenge.用反向遗传学生产的H5N1流感疫苗进行免疫接种可保护雪貂免受同源和异源攻击。
J Infect Dis. 2006 Jul 15;194(2):159-67. doi: 10.1086/505225. Epub 2006 Jun 9.
7
Oseltamivir resistance during treatment of influenza A (H5N1) infection.甲型H5N1流感感染治疗期间的奥司他韦耐药性。
N Engl J Med. 2005 Dec 22;353(25):2667-72. doi: 10.1056/NEJMoa054512.
8
Pathology of human influenza A (H5N1) virus infection in cynomolgus macaques (Macaca fascicularis).食蟹猴（猕猴属）感染甲型H5N1流感病毒的病理学研究
Vet Pathol. 2003 May;40(3):304-10. doi: 10.1354/vp.40-3-304.
9
Immunization of macaques with formalin-inactivated respiratory syncytial virus (RSV) induces interleukin-13-associated hypersensitivity to subsequent RSV infection.用福尔马林灭活的呼吸道合胞病毒（RSV）对猕猴进行免疫会诱导与白细胞介素-13相关的对后续RSV感染的超敏反应。
J Virol. 2002 Nov;76(22):11561-9. doi: 10.1128/jvi.76.22.11561-11569.2002.
10
Immunopathogenesis of vaccine-enhanced RSV disease.疫苗增强型呼吸道合胞病毒疾病的免疫发病机制。
Vaccine. 2001 Oct 15;20 Suppl 1:S27-31. doi: 10.1016/s0264-410x(01)00301-2.
Zotero 插件